Involvement of the nucleus accumbens in stimulation of the immune response in rats after activation of opioid μ receptors with DAGO

Neuroscience and Behavioral Physiology

Volumn 32, Issue 5, 2002, Pages 529-532

  Devoino, L V ^a   Cheido, M A ^a   Al'perina, E L ^a  

^a SCIENTIFIC RESEARCH INSTITUTE OF PHYSIOLOGY AND BASIC MEDICINE   (Russian Federation)

Author keywords

DAGO; Dopaminergic system; Immunostimulation; Nucleus accumbens; Opioid receptor agonist

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; IMMUNOGLOBULIN M ANTIBODY; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; ELECTROLYSIS; ERYTHROCYTE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOSTIMULATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; RAT; ROSETTE FORMING CELL; SHEEP ERYTHROCYTE;

ANALGESICS, OPIOID; ANIMALS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; HEMOLYTIC PLAQUE TECHNIQUE; IMMUNOGLOBULIN M; MALE; NEUROIMMUNOMODULATION; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; ROSETTE FORMATION;

EID: 0036710912     PISSN: 00970549     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1019815824348     Document Type: Article

References (36)

1. E. L. Al'perina, "Involvement of dopaminergic structures of the brain in neuroimmunomodulation," Byull Sib. Otdel Ros. Akad. Med. Nauk, 4, 40-45 (1994).
2. L. V. Devoino, and R. Yu. Il'yuchenok, Neuromediator Systems in Psychoneuroimmunomodulation: Serotonin, GABA, Neuropeptides [in Russian], TsÉRIS, Novosibirsk (1993).
3. L. V. Devoino, M. A. Cheido, and E. L. Al'perina, "Involvement of the rat caudate nucleus in mediating the immunostimulatory effect of DAGO," Ros. Fiziol. Zh. im. I. M. Sechenova, 86, No. 12, 135-139 (2000).
4. M. A. Cheido and G. V. Idova, "Involvement of opiate δ receptors in immunomodulation, Ros. Fiziol. Zh. im. I. M. Sechenova, 79, No. 12, 18-22 (1993).
5. M. A. Cheido, G. V. Idova, and L. V. Devoino, "Serotonin-dependent suppression of immune responses by kappa-opioid receptors," Byull. Éksp. Biol. Med., 9, 91-292 (1993).
6. M. A. Cheido and G. V. Idova, "Dopaminergic mechanisms in the immunostimulating effect of μ opioid receptors," Byull. Éksp. Biol. Med., 4, 373-375 (1996).
7. M. A. Cheido and G. V. Idova, "The effects of opioid receptors on the immunomodulation processes," Ros. Fiziol. Zh. im. I. M. Sechenova, 84, No. 4, 385-390 (1998).
8. 1 receptors," Neurosci. Lett., 256, No. 2, 61-64 (1998).
9. M. Cheido, G. Idova, and L. Devoino, "Involvement of delta opioid receptors in immunosuppression," Internat. J. Neurosci., 84, 195-203 (1996).
10. 1 and delta opioid receptors," Psychopharmacology, 120, No. 3, 347-355 (1995).
11. A. J. Cunningham, "A method of increased sensitivity for detecting single antibody-forming cells," Nature, 207, 1106-1107 (1965).
12. S. T. Cunningham and A. E. Kelley, "Opiate infusion into the nucleus accumbens: contrasting effects on motor activity and responding for conditioned reward," Brain Res., 588, 104-114 (1992).
13. L. V. Devoino, L. S. Eliseeva, G. V. Idova, and M. A. Cheido, "5-Hydroxytryptophan effect on the development of the immune response: IgM- and IgG-antibodies and rosette formation in primary and secondary responses," Eur. J. Immunol., 5, 394-399 (1975).
14. L. Devoino, E. Alperina, J. Galkina, and R. Ilyutchenok, "Involvement of brain dopaminergic structures in neuroimmunomodulation," Internat. J. Neurosci., 93, No. 3-4, 213-228 (197).
15. G. Di Chiara and A. Imperato, "Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats," J. Pharmacol. Exp. Ther., 244, 1067-1080 (1988).
16. Y. Q. Ding, T. Kaneko, S. Nomura, and N. Mizuno, "Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat," J. Comp. Neurol., 367, No. 3, 375-402 (199).
17. H. S. Haas and K. Schauenstein, "Neuroimmunomodulation via limbic structures - the neuroanatomy of psychoimmunology," Progr. Neurobiol., 51, No. 2, 195-222 (1997).
18. P. W. Kalivas and P. Duffy, "Effect of acute and daily neurotensin and enkephalin and enkephalin treatments on extracellular dopamine in the nucleus accumbens," J. Neurosci., 10, 1940-2949 (1990).
19. K. Kamata, "Pharmacological studies on the interrelation between the dopaminergic, GABAergic, and opioid peptidergic systems in the central nervous system of the rat," Japanese. J. Pharmacol., 45, 439-447 (1987).
20. J. F. R. Konig and R. A. Klippel, The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem, Baltimore (1963).
21. J. Kowalski, "Immunomodulatory action of class mu-, delta- and kappa-opioid receptor agonists in mice," Neuropeptides, 32, No. 4, 301-306 (1998).
22. 2 dopamine receptors in the medial prefrontal cortex of the rat," Psychopharmacology, 95, 255-257 (1988).
23. A. Mansour, H. Khachaturian, M. E. Lewis, H. Akil, and S. J. Watson, "Anatomy of CNS opioid receptors," Trends Neurosci., 11, 308-314 (1988).
24. E. L. Morgan, "Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (mu-, kappa- and delta) selective agonists," J. Neuroimmunol., 65, No. 1, 21-30 (1996).
25. 1 receptors in the limbic system in the control of immune mechanisms," Neuroimmunomodulation, 1, No. 3, 174-180 (1994).
26. 1 receptors in the amygdala enhance the immune response in the rat," Ann. N.Y. Acad. Sci., 741, 316-323 (1994).
27. C. M. A. Pennartz, M. J. Groenewegen, and F. H. Lopes da Silva, "The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioral, electrophysiological and anatomic data," Progr. Neurobiol., 42, 719-723 (1994).
28. 1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission," Pharmacol. Biochem. Behav., 63, No. 2, 245-252 (1999).
29. 5-enkephalinamide into the ventral tegmental area," Behav. Brain. Res., 5, 225-229 (1982).
30. J. Raduloic and B. D. Jankovic, "Opposing activities of brain opioid receptors in the regulation of humoral and cell-mediated immune responses in the rat," Brain Res., 661, 189-195 (1994).
31. J. Radulovic, Z. Mancev, S. Stanojevic, T. Vasiljevic, V. Kovacevic-Jovanovic, and G. Pesic, "Modulation of humoral immune response by central administration of leucine-enkephalin: effect of mu, delta and kappa opioid receptor antagonists," J. Neuroimmunol., 65, No. 2, 155-161 (1996).
32. N. A. Sharif, and J. Hugher, "Discrete mapping of brain mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors," Peptide, 10, No. 3, 499-522 (1989).
33. N. R. Swerdlow, M. Amarlic, and G. F. Koob, "Nucleus accumbens opiate-dopamine interaction and locomotor activation in the rat. Evidence for a pre-synaptic locus," Pharmacol. Biochem. Behav., 26, 765-770 (1987).
34. 4, Gly-ol]enkephalin) specifically reverses apomorphine-induced increases in rearing and grooming behaviors in the mouse," Brain Res., 557, 77-82, (1991).
35. H. Yokoo, and S. Yamada, M. Yoshida, and T. Tanaka, "Effect of opioid peptides on dopamine release from nucleus accumbens after repeated treatment with methamphetamine," Eur. J. Pharmacol., 256, 335-338 (1994).
36. R. L. Zastawny, S. R. George, T. Nguyen, R. Cheng, J. Tsatsos, R. Briones-Urbina, and B. F. O'Dowd, "Cloning, characterization, and distribution of a mu-opioid receptor in rat brain," J. Neurochem., 62, No. 6, 2099-2105 (1994).